Transgene SA
Utility Patent Applications

Last updated:

List of all Transgene SA patents 6 in total

Status Patent
Application
Utility: M2-DEFECTIVE POXVIRUS External link
Filling date: 9 Sep 2025 Issue date: 24 Feb 2022
Application
Utility: NOVEL ANTIBODIES AND NUCLEOTIDE SEQUENCES, AND USES THEREOF External link
Filling date: 9 Sep 2025 Issue date: 10 Feb 2022
Application
Utility: COMBINATION OF ONCOLYTIC VIRUS WITH IMMUNE CHECKPOINT MODULATORS External link
Filling date: 9 Sep 2025 Issue date: 3 Dec 2020
Application
Utility: ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS External link
Filling date: 9 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: ONCOLYTIC VIRUSES AND THERAPEUTIC MOLECULES External link
Filling date: 9 Sep 2025 Issue date: 31 Oct 2019
Application
Utility: IMMUNOTHERAPEUTIC PRODUCT AND MDSC MODULATOR COMBINATION THERAPY External link
Filling date: 9 Sep 2025 Issue date: 31 Oct 2019

Showing 1 to 6 of 6 patents.